Review Article

Using Boron Supplementation in Cancer Prevention and Treatment: A Review Article

somayeh Nikkhah , Mohammad Reza Naghii

somayeh Nikkhah
. Email:

Mohammad Reza Naghii
Baqiyatallah (a.s.) University of Medical Sciences, Tehran
Online First: September 29, 2017 | Cite this Article
Nikkhah, s., Naghii, M. 2017. Using Boron Supplementation in Cancer Prevention and Treatment: A Review Article. The Cancer Press 3(3): 113-119. DOI:10.15562/tcp.56

Cancer is a multistage and multifactorial process in which genetic and environmental factors contribute to it. The results of the studies indicate the effective role of micronutrients, vitamins, and minerals in the treatment of malignancies. One of these elements, endorsed by the American Food and Drug Administration, is boron supplements. The present study reviews the role of boron supplementation in the prevention and treatment of cancer. At ISI, Pub Med, Science Direct, Google Scholar, Scopus, Iranmedex and Magiran  databases, we examined 41 studies conducted in the years 1988-2018 regarding the effect of boron supplementation on cancer. The results showed that boron supplement is a useful and essential ingredient for humans with a daily intake of about 1-3 mg per day. Its rich diets have a significant reduction in the risk of developing a variety of cancers including prostate, breast, cervix and lung, liver, melanoma. The mechanisms by which boron may influence cancer is still unknown, but evidence suggests that boron has antioxidant and anti-inflammatory properties. Proposed mechanisms related to boron activity in cancer cells include inhibition of proteasezonin enzymatic activity, dehydrogenase, mRNA modification, and cell division and induction of apoptosis. Boron-containing compounds indicate promising effects for chemotherapy types of cancer.
Its concluded that low levels of boron should be considered as a concern for health, and increasing the consumption of boron with its rich diets should be recognized as a rational and reasonable diet recommendation for the prevention and treatment of cancer, promotion of health and well-being.



Jupp P. A Complex Systems Approach to Cancer Prevention. Medical Hypotheses.

Hunn J, Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clinical obstetrics and gynecology. 2012;55(1):3-23.

Pourhoseingholi MA, Zali MR. Colorectal cancer screening: Time for action in Iran. World journal of gastrointestinal oncology. 2012;4(4):82.

Mosavi-Jarrahi A, Mohagheghi MA. Epidemiology of esophageal cancer in the high-risk population of Iran. Asian Pacific Journal of Cancer Prevention. 2006;7(3):375.

Bekelman DB, Dy SM, Becker DM, Wittstein IS, Hendricks DE, Yamashita TE, et al. Spiritual well-being and depression in patients with heart failure. Journal of general internal medicine. 2007;22(4):470-7.

Kamian S. Effectiveness of Spiritual Health Education on Increasing Hope among Breast Cancer Patients. Iranian Journal of Health Education & Promotion. 2014;2(3):208.

Logan J, Bourassa MW. The rationale for a role for diet and nutrition in the prevention and treatment of cancer. European Journal of Cancer Prevention. 2018.

Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison's principles of internal medicine. 18 ed: McGraw Hill Professional; 2011.

Nikkhah S, Dolatian M, Naghii MR, Zaeri F, Taheri SM. Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea. Complementary therapies in clinical practice. 2015;21(2):79-83.

Pouchieu C, Fassier P, Druesne-Pecollo N, Zelek L, Bachmann P, Touillaud M, et al. Dietary supplement use among cancer survivors of the NutriNet-Sante cohort study. British Journal of Nutrition. 2015;113(8):1319-29.

Harvie M, editor Nutritional supplements and cancer: potential benefits and proven harms. American Society of Clinical Oncology educational book American Society of Clinical Oncology Meeting; 2014.

Bours MJ, Beijer S, Winkels RM, van Duijnhoven FJ, Mols F, Breedveld-Peters JJ, et al. Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry. British Journal of Nutrition. 2015;114(2):286-96.

Song S, Youn J, Lee YJ, Kang M, Hyun T, Song Y, et al. Dietary supplement use among cancer survivors and the general population: a nation-wide cross-sectional study. BMC cancer. 2017;17(1):891.

Li C, Hansen RA, Chou C, Calderón AI, Qian J. Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014. Cancer. 2017.

Ledda A, Belcaro G, Dugall M, Luzzi R, Hosoi M, Feragalli B, et al. A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study. European review for medical and pharmacological sciences. 2017;21(18):4196-202.

Nielsen FH, Meacham SL. Growing evidence for human health benefits of boron. Journal of Evidence-Based Complementary & Alternative Medicine. 2011;16(3):169-80.

Fort DJ, Propst TL, Stover EL, Strong PL, Murray FJ. Adverse reproductive and developmental effects inXenopus from insufficient boron. Biological trace element research. 1998;66(1-3):237-59.

Ross A, Caballero B, Cousins R, Tucker K, Ziegler T. Modern nutrition in health and disease. Heart. 1. 11 ed. London: Lippincot Williams & Wolters Kluwer business; 2014. p. 248-51.

Acerbo AS, Miller LM. Assessment of the chemical changes induced in human melanoma cells by boric acid treatment using infrared imaging. Analyst. 2009;134(8):1669-74.

Dinca L, Scorei R. Boron in human nutrition and its regulations use. Journal of Nutritional Therapeutics. 2013;2(1):22-9.

Meacham S, Karakas S, Wallace A, Altun F. Boron in human health: evidence for dietary recommendations and public policies. Open Mineral Processing Journal. 2010;3(1):36-53.

Board NAoSIoMFaN. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. 2001:510-21.

Nielsen FH. Manganese, Molybdenum, Boron, Chromium, and Other Trace Elements 2012. 10:[586-607].

Liao SF, Monegue JS, Lindemann MD, Cromwell GL, Matthews JC. Dietary supplementation of boron differentially alters expression of borate transporter (NaBCl) mRNA by jejunum and kidney of growing pigs. Biological trace element research. 2011;143(2):901-12.

Scorei RI, Rotaru P. Calcium fructoborate—potential anti-inflammatory agent. Biological trace element research. 2011;143(3):1223-38.

Scorei RI, Popa R. Sugar-Borate Esters–Potential Chemical Agents in Prostate Cancer Chemoprevention. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2013;13(6):901-9.

Naghii MR, Einollahi B, Rostami Z. Preliminary evidence hints at a protective role for boron in urolithiasis. The Journal of Alternative and Complementary Medicine. 2012;18(3):207-9.

Naghii M. Boron and antioxidants complex: a new concept for the treatment of kidney stones without rigorous pain. Endocr Regul. 2014;48:120-5.

Nielsen FH. Update on human health effects of boron. Journal of Trace Elements in Medicine and Biology. 2014;28(4):383-7.

Scorei R. Boron compounds in the breast cancer cells chemoprevention and chemotherapy. Breast cancer–current and alternative therapeutic modalities InTech, Rijeca. 2011:91-114.

Yamamura J, Kamigaki S, Tsujie M, Fujita J, Osato H. The difference in prognostic outcomes between de novo stage IV and recurrent metastatic patients with hormone receptor-positive, HER2-negative breast cancer: a single-center study. Annals of Oncology. 2016;27(suppl_6).

McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of Clinical Oncology. 2003;21(10):1961-6.

Hofling M, Hirschberg AL, Skoog L, Tani E, Hägerström T, von Schoultz B. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause. 2007;14(2):183-90.

Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour M-S. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. Journal of Trace Elements in Medicine and Biology. 2011;25(1):54-8.

Colston K. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocrine-related cancer. 2002;9(1):45-59.

Scorei R. Is boron a prebiotic element? A mini-review of the essentiality of boron for the appearance of life on Earth. Origins of Life and Evolution of Biospheres. 2012;42(1):3-17.

Müezzinoğlu T, Korkmaz M, Neşe N, Bakırdere S, Arslan Y, Ataman OY, et al. Prevalence of prostate cancer in high boron-exposed population: a community-based study. Biological trace element research. 2011;144(1-3):49-57.

Korkmaz M, Uzgören E, Bakırdere S, Aydın F, Ataman OY. Effects of dietary boron on cervical cytopathology and on micronucleus frequency in exfoliated buccal cells. Environmental toxicology. 2007;22(1):17-25.

Mahabir S, Spitz M, Barrera S, Dong Y, Eastham C, Forman M. Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. American journal of epidemiology. 2008;167(9):1070-80.

Zafar H, Ali S. Boron inhibits the proliferating cell nuclear antigen index, molybdenum containing proteins and ameliorates oxidative stress in hepatocellular carcinoma. Archives of biochemistry and biophysics. 2013;529(2):66-74.

Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis. 2000;21(3):525-30

No Supplementary Material available for this article.
Article Views      : 671
PDF Downloads : 268